Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sarepta Theraps drug EXONDYS 51 appeared first on DrugP…
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are fifty-six patents…
The post New patent for Amarin Pharms drug VASCEPA appeared first on Dru…
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in two NDAs. It is available from two suppliers. There are twenty-six patents…
The post New patent for Salix Pharms drug XIFAXAN appeared first on Dru…
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. There are twelve patents protecting this drug. This drug…
The post New patent for Amicus Theraps drug GALAFOLD appeared first on Dr…
Annual Drug Patent Expirations for VITRAKVI Vitrakvi is a drug marketed by Bayer Hlthcare and Bayer Healthcare and is included in two NDAs. It is available from one supplier. There…
The post New patent for Bayer Hlthcare drug VITRAKVI appeared first on…
Annual Drug Patent Expirations for VITRAKVI Vitrakvi is a drug marketed by Bayer Hlthcare and Bayer Healthcare and is included in two NDAs. It is available from one supplier. There…
The post New patent for Bayer Healthcare drug VITRAKVI appeared first …
Annual Drug Patent Expirations for TRULANCE Trulance is a drug marketed by Salix and is included in one NDA. It is available from two suppliers. There are eight patents protecting…
The post New patent for SALIX drug TRULANCE appeared first on DrugPaten…
Annual Drug Patent Expirations for PLENVU Plenvu is a drug marketed by Salix and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for SALIX drug PLENVU appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on…